AIM ImmunoTech (AMEX:AIM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does AIM ImmunoTech (AIM) operate in?

AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

AIM ImmunoTech Stock (AMEX: AIM) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 233.63K
Day Range	- - -
52 Wk Range	0.25 - 0.62
Market Cap	$17.04M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	39
Short Interest	0.93%
Days to Cover	1.57

Recent News

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About AIM ImmunoTech Inc

Sector

Health Care

Industry

Biotechnology

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AIM ImmunoTech (AIM) stock?

You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.

View our list of the best stock brokerages

Who are AIM ImmunoTech (AIM) competitors?

Other companies in AIM ImmunoTech’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).

What is the forecast, or price target, for AIM ImmunoTech (AIM) stock?

AIM ImmunoTech has a consensus price target of $5.00.

What is the current price for AIM ImmunoTech (AIM)?

The stock price for AIM ImmunoTech (AMEX: AIM) is $0.2983 last updated September 18, 2024 at 8:00 PM EDT.

Does AIM ImmunoTech (AIM) pay a dividend?

There are no upcoming dividends for AIM ImmunoTech.

When is AIM ImmunoTech (AMEX:AIM) reporting earnings?

AIM ImmunoTech’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is AIM ImmunoTech (AIM) going to split?

There is no upcoming split for AIM ImmunoTech.

What sector and industry does AIM ImmunoTech (AIM) operate in?

AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now